Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Homobivalent, Trivalent, and Covalent PROTACs: Emerging Strategies for Protein Degradation. | J Med Chem | 2022 | 35763424 | PubTator, text mining | PubMed |
| Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cells. | J Clin Invest | 2022 | 35763353 | PubTator, text mining | PubMed |
| Discovery of pomalidomide-based PROTACs for selective degradation of histone deacetylase 8. | Eur J Med Chem | 2022 | 35759908 | PubTator, text mining | PubMed |
| Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach. | Front Cell Dev Biol | 2022 | 35757005 | PubTator, text mining | PubMed |
| Repurposing a DNA-Repair Enzyme for Targeted Protein Degradation. | Chembiochem | 2022 | 35750646 | PubTator, text mining | PubMed |
| Targeted Degradation of mRNA Decapping Enzyme DcpS by a VHL-Recruiting PROTAC. | ACS Chem Biol | 2022 | 35749470 | PubTator, text mining | PubMed |
| Distinct interactors define the p63 transcriptional signature in epithelial development or cancer. | Biochem J | 2022 | 35748701 | PubTator, text mining | PubMed |
| HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer. | Pharmaceuticals (Basel) | 2022 | 35745586 | PubTator, text mining | PubMed |
| The Development of FAK Inhibitors: A Five-Year Update. | Int J Mol Sci | 2022 | 35742823 | PubTator, text mining | PubMed |
| Application and Design of Switches Used in CAR. | Cells | 2022 | 35741039 | PubTator, text mining | PubMed |
| Rapid and specific degradation of endogenous proteins in mouse models using auxin-inducible degrons. | Elife | 2022 | 35736539 | PubTator, text mining | PubMed |
| PROTAC Degraders with Ligands Recruiting MDM2 E3 Ubiquitin Ligase: An Updated Perspective. | Acta Mater Med | 2022 | 35734447 | PubTator, text mining | PubMed |
| The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum. | Front Med (Lausanne) | 2022 | 35733868 | PubTator, text mining | PubMed |
| CF-PPiD technology based on cell-free protein array and proximity biotinylation enzyme for in vitro direct interactome analysis. | Sci Rep | 2022 | 35732899 | PubTator, text mining | PubMed |
| Circ_UBE2D2 Attenuates the Progression of Septic Acute Kidney Injury in Rats by Targeting miR-370-3p/NR4A3 Axis. | J Microbiol Biotechnol | 2022 | 35722711 | PubTator, text mining | PubMed |
| Structure-activity relationship analysis of novel GSPT1 degraders based on benzotriazinone scaffold and its antitumor effect on xenograft mouse model. | Bioorg Chem | 2022 | 35717803 | PubTator, text mining | PubMed |
| Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation. | Chem Soc Rev | 2022 | 35713468 | PubTator, text mining | PubMed |
| The Inflamm-Aging Model Identifies Key Risk Factors in Atherosclerosis. | Front Genet | 2022 | 35706446 | PubTator, text mining | PubMed |
| Targeting the immune microenvironment in mantle cell lymphoma: implications for current and emerging therapies. | Leuk Lymphoma | 2022 | 35704674 | PubTator, text mining | PubMed |
| PROTACs for BRDs proteins in cancer therapy: a review. | J Enzyme Inhib Med Chem | 2022 | 35702740 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=58